Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Healthcare Drug Manufacturers - Specialty & Generic
Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

Recent & Breaking News (TSXV:VM)

Voyageur Minerals Announces Director Changes

GlobeNewswire August 7, 2019

Voyageur Closes First Tranche of Non-Brokered Private Placement

GlobeNewswire July 29, 2019

Voyageur Announces Financing of $400,000

GlobeNewswire July 11, 2019

Voyageur Minerals Announces Management Change with New CEO and Director Appointments

GlobeNewswire July 4, 2019

Voyageur Announces the Closing of a $240,651.52 Private Placement

GlobeNewswire May 8, 2019

Voyageur Announces Financing of $400,000

GlobeNewswire April 26, 2019

Voyageur Progress Update

GlobeNewswire March 6, 2019

IIROC Trading Resumption - VM

Canada NewsWire February 8, 2019

Voyageur Minerals Begins Preliminary Feasibility –Clarification of Feb 5, 2018 press release

GlobeNewswire February 8, 2019

IIROC Trading Halt - VM

Canada NewsWire February 6, 2019

Voyageur Minerals Begins Preliminary Feasibility

GlobeNewswire February 6, 2019

Voyageur Minerals Submits Its Bulk Sample Permit Application for 10,000 Tonnes at Its Barite Property

GlobeNewswire January 21, 2019

ImagingX Pharmaceuticals Inc. formed by Voyageur Minerals and Chief Medical

GlobeNewswire January 9, 2019

Voyageur Engages Xnergy Financial Investment Banking

GlobeNewswire January 3, 2019

Voyageur Minerals Signs Joint Venture with Chief Medical Supply to Begin Manufacturing Barium Contrast Pharmaceutical Products

GlobeNewswire November 8, 2018

Voyageur Announces the Closing of a $188,000 Private Placement

GlobeNewswire October 31, 2018

Voyageur Announces Closing of Second Tranche of the Private Placement

GlobeNewswire August 29, 2018

Voyageur Announces Signing of LOI With Manufacturer of Contrast Suspension Products

GlobeNewswire August 14, 2018

Voyageur Announces Issuance of 2018 NI 43-101

GlobeNewswire July 23, 2018

Voyageur Announces High Grade Resource. Initiates Steps of Creating Barium Contrast Suspension Products

GlobeNewswire July 5, 2018